BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10329350)

  • 1. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
    Lefebvre S; Moreau P; Dausset J; Carosella ED; Paul P
    Placenta; 1999 May; 20(4):293-301. PubMed ID: 10329350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal trophoblasts resist induction of class I HLA.
    Hunt JS; Andrews GK; Wood GW
    J Immunol; 1987 Apr; 138(8):2481-7. PubMed ID: 3104468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
    Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
    Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
    Moreau P; Paul P; Gourand L; Prost S; Dausset J; Carosella E; Kirszenbaum M
    Hum Immunol; 1997 Jan; 52(1):41-6. PubMed ID: 9021408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
    Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
    Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
    Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
    Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of HLA class I expression: is HLA-G the odd one out?
    Gobin SJ; van den Elsen PJ
    Semin Cancer Biol; 1999 Feb; 9(1):55-9. PubMed ID: 10092551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.